Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3507-3511

  Suzuki, Kazuhiro ^a   Ohtake, Nobuaki ^a   Nakata, Seiji ^a   Takei, Tomoyuki ^a   Matsui, Hiroshi ^a   Ono, Yoshihiro ^a   Nakazato, Haruki ^a   Hasumi, Masaru ^a   Koike, Hidekazu ^a   Ito, Kazuto ^a   Fukabori, Yoshitatsu ^a   Kurokawa, Kohei ^a   Yamanaka, Hidetoshi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

HPC2 ELAC2; Japanese; Prostate cancer

Indexed keywords

ALANINE; LEUCINE; SERINE; THREONINE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FAMILY HISTORY; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HPC2 ELAC2 GENE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSTATIC NEOPLASMS;

EID: 0036875516     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Smith JR, Freije D, Carpten JD, Grongerg M, Xu J, Issacs SD, Brownstein MJ, Bova GS Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM and Issacs WB: Major susceptibility locus for prostate cancer on chromosome 1 sugggested by a genome-wide search. Science 274: 1371-1374, 1996.
2. Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wohr G and Latil A: Predisponsing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 62: 1416-1424, 1998.
3. Xu J, Mayers D, Freije D, Issacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Issacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallionimi OP, Berry R, Schaid D, French A, McDonnell S, Schroeder J, Blute M, Thibodeau S and Trent J: Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 20: 175-179, 1998.
4. Gibbs M, Stanford JL, McIndoe TA, Jarvik GP, Kolb S, Goode EL, Chakrabarti L, Schuster EF, Buckley VA, Miller EL, Brandzel S, Li S, Hood L and Ostrander EA: Evidence for a rare prostate cancer-susceptibility locus at chromosome lp36. Am J Hum Genet 64: 776-787, 1999.
5. Berry R, Schroeder JJ, French AJ, McDonnell SK, Peterson BJ, Cunningham JM, Thibodeau SN and Schaid DJ: Evidence for prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 67: 82-91, 2000.
6. Tavtigian SV, Simard J, Teng DHF, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swenson J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J and Cannon-Albright LA: A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27: 172-180, 2001.
7. Rebbeck TR, Walker AH, Zeigler-Johnson C, Weisburg S, Martin AM, Nathanson KL, Wein AJ and Malkowicz S: Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet 67: 1024-1029, 2000.
8. Vesprini D, Nam RK, Trachtenberg J, Jewett MAS, Tavtigian SV, Emani M, Ho M, Toi A and Narod SA: HPC2 variants and screen detected prostate cancer. Am J Hum Genet 68: 912-917, 2001.
9. Suarez BK, Gerhard DS, Lin J, Haverer B, Nguyen L, Kesterson NK and Catalona WJ: Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in nultiplex families and healthy controls. Cancer Res 61: 4982-4984, 2001.
10. Rökman A, Ikonen T, Mononen N, Autio V, Matikainen MP, Koivisto PA, Tammela TLJ, Kallioniemi OP and Schleutker J: ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer. Cancer Res 61: 6038-6041, 2001.
11. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ and Thibodeau SN: Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res 61: 6494-9649, 2001.
12. Xu J, Zheng SL, Carpten JD, Nupponen NN, Robbins CM, Mestre J, Moses TY, Faith DA, Kelly BD, Isaacs SD, Wiley KE, Ewing CM, Bujnovszky P, Chang BL, Bailey-Wilson J, Bleecker ER, Walsh PC, Trent JM, Meyers DA and Isaacs WB: Evaluation of linkage and associaton of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet 68: 901-911, 2001.
13. Wu YQ, Chen H, Rubin MA, Wojno KJ and Coony KA: Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer. Cancer Res 61: 8651-8653, 2001.